STAAR Surgical Cash Flow from Financial Activities 2010-2025 | STAA
STAAR Surgical cash flow from financial activities from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
STAAR Surgical Annual Cash Flow Financial
(Millions of US $) |
| 2024 |
$6 |
| 2023 |
$7 |
| 2022 |
$8 |
| 2021 |
$18 |
| 2020 |
$20 |
| 2019 |
$0 |
| 2018 |
$75 |
| 2017 |
$2 |
| 2016 |
$3 |
| 2015 |
$5 |
| 2014 |
$3 |
| 2013 |
$2 |
| 2012 |
$4 |
| 2011 |
$3 |
| 2010 |
$-12 |
| 2009 |
$7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.952B |
$0.314B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
